Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Mitochondrial-based Therapeutics Market Insights, Forecast to 2030

Global Mitochondrial-based Therapeutics Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published: 2024-04-09

Pages: 109 Pages

Report ld: 2866857

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Mitochondria are therefore vital for normal cellular function, including intracellular metabolic activities and signal transduction of various cellular pathways. They are involved in cellular ion homeostasis, oxidative stress, and apoptotic and necrotic cell death.

Market Analysis and Insights: Global Mitochondrial-based Therapeutics Market

Mitochondrial-based Therapeutics Market Size

M= millions and B=billions

The global Mitochondrial-based Therapeutics market is projected to grow from US$ 415 million in 2024 to US$ 651.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:
This report presents an overview of global market for Mitochondrial-based Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Mitochondrial-based Therapeutics, also provides the revenue of main regions and countries. of the upcoming market potential for Mitochondrial-based Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mitochondrial-based Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Mitochondrial-based Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Mitochondrial-based Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Report Metric
Details
Report Title
Global Mitochondrial-based Therapeutics Market Insights, Forecast to 2030
Forecasted Market Size in 2030
US$ 651.3 million
CAGR(2024-2030)
7.8%
Market Size Available for Years
2019-2030
Global Mitochondrial-based Therapeutics Companies Covered
Reneo Pharmaceutical, Pfizer Inc., Norvartis AG, Takeda Pharmaceuticals, Amgen Inc., NeuroVive Pharmaceutical AB, Entogene AG, Stealth Biotherapeutics, Ixchel Pharma, Reata Pharmaceuticals
Global Mitochondrial-based Therapeutics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mitochondrial-based Therapeutics Market, Segment by Type
Oral

Intravenous
Global Mitochondrial-based Therapeutics Market, Segment by Application
Mitochondrial Myopathy

Leber’s heredity Optic Neuropathy

Leigh Syndrome

Mitochondrial DNA Depletion Syndrome

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Mitochondrial-based Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mitochondrial-based Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mitochondrial-based Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Mitochondrial-based Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Oral
        1.2.3 Intravenous
    1.3 Market by Application
        1.3.1 Global Mitochondrial-based Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Mitochondrial Myopathy
        1.3.3 Leber’s heredity Optic Neuropathy
        1.3.4 Leigh Syndrome
        1.3.5 Mitochondrial DNA Depletion Syndrome
        1.3.6 Other
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Mitochondrial-based Therapeutics Market Perspective (2019-2030)
    2.2 Global Mitochondrial-based Therapeutics Growth Trends by Region
        2.2.1 Mitochondrial-based Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Mitochondrial-based Therapeutics Historic Market Size by Region (2019-2024)
        2.2.3 Mitochondrial-based Therapeutics Forecasted Market Size by Region (2025-2030)
    2.3 Mitochondrial-based Therapeutics Market Dynamics
        2.3.1 Mitochondrial-based Therapeutics Industry Trends
        2.3.2 Mitochondrial-based Therapeutics Market Drivers
        2.3.3 Mitochondrial-based Therapeutics Market Challenges
        2.3.4 Mitochondrial-based Therapeutics Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Revenue Mitochondrial-based Therapeutics by Players
        3.1.1 Global Mitochondrial-based Therapeutics Revenue by Players (2019-2024)
        3.1.2 Global Mitochondrial-based Therapeutics Revenue Market Share by Players (2019-2024)
    3.2 Global Mitochondrial-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Mitochondrial-based Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Mitochondrial-based Therapeutics Market Concentration Ratio
        3.4.1 Global Mitochondrial-based Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Mitochondrial-based Therapeutics Revenue in 2023
    3.5 Global Key Players of Mitochondrial-based Therapeutics Head office and Area Served
    3.6 Global Key Players of Mitochondrial-based Therapeutics, Product and Application
    3.7 Global Key Players of Mitochondrial-based Therapeutics, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Mitochondrial-based Therapeutics Breakdown Data by Type
    4.1 Global Mitochondrial-based Therapeutics Historic Market Size by Type (2019-2024)
    4.2 Global Mitochondrial-based Therapeutics Forecasted Market Size by Type (2025-2030)

 5 Mitochondrial-based Therapeutics Breakdown Data by Application
    5.1 Global Mitochondrial-based Therapeutics Historic Market Size by Application (2019-2024)
    5.2 Global Mitochondrial-based Therapeutics Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Mitochondrial-based Therapeutics Market Size (2019-2030)
    6.2 North America Mitochondrial-based Therapeutics Market Size by Type
        6.2.1 North America Mitochondrial-based Therapeutics Market Size by Type (2019-2024)
        6.2.2 North America Mitochondrial-based Therapeutics Market Size by Type (2025-2030)
        6.2.3 North America Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    6.3 North America Mitochondrial-based Therapeutics Market Size by Application
        6.3.1 North America Mitochondrial-based Therapeutics Market Size by Application (2019-2024)
        6.3.2 North America Mitochondrial-based Therapeutics Market Size by Application (2025-2030)
        6.3.3 North America Mitochondrial-based Therapeutics Market Share by Application (2019-2030)
    6.4 North America Mitochondrial-based Therapeutics Market Size by Country
        6.4.1 North America Mitochondrial-based Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Mitochondrial-based Therapeutics Market Size by Country (2019-2024)
        6.4.3 North America Mitochondrial-based Therapeutics Market Size by Country (2025-2030)
        6.4.4 United States
        6.4.5 Canada

 7 Europe
    7.1 Europe Mitochondrial-based Therapeutics Market Size (2019-2030)
    7.2 Europe Mitochondrial-based Therapeutics Market Size by Type
        7.2.1 Europe Mitochondrial-based Therapeutics Market Size by Type (2019-2024)
        7.2.2 Europe Mitochondrial-based Therapeutics Market Size by Type (2025-2030)
        7.2.3 Europe Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    7.3 Europe Mitochondrial-based Therapeutics Market Size by Application
        7.3.1 Europe Mitochondrial-based Therapeutics Market Size by Application (2019-2024)
        7.3.2 Europe Mitochondrial-based Therapeutics Market Size by Application (2025-2030)
        7.3.3 Europe Mitochondrial-based Therapeutics Market Share by Application (2019-2030)
    7.4 Europe Mitochondrial-based Therapeutics Market Size by Country
        7.4.1 Europe Mitochondrial-based Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Mitochondrial-based Therapeutics Market Size by Country (2019-2024)
        7.4.3 Europe Mitochondrial-based Therapeutics Market Size by Country (2025-2030)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries

 8 China
    8.1 China Mitochondrial-based Therapeutics Market Size (2019-2030)
    8.2 China Mitochondrial-based Therapeutics Market Size by Type
        8.2.1 China Mitochondrial-based Therapeutics Market Size by Type (2019-2024)
        8.2.2 China Mitochondrial-based Therapeutics Market Size by Type (2025-2030)
        8.2.3 China Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    8.3 China Mitochondrial-based Therapeutics Market Size by Application
        8.3.1 China Mitochondrial-based Therapeutics Market Size by Application (2019-2024)
        8.3.2 China Mitochondrial-based Therapeutics Market Size by Application (2025-2030)
        8.3.3 China Mitochondrial-based Therapeutics Market Share by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Mitochondrial-based Therapeutics Market Size (2019-2030)
    9.2 Asia Mitochondrial-based Therapeutics Market Size by Type
        9.2.1 Asia Mitochondrial-based Therapeutics Market Size by Type (2019-2024)
        9.2.2 Asia Mitochondrial-based Therapeutics Market Size by Type (2025-2030)
        9.2.3 Asia Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    9.3 Asia Mitochondrial-based Therapeutics Market Size by Application
        9.3.1 Asia Mitochondrial-based Therapeutics Market Size by Application (2019-2024)
        9.3.2 Asia Mitochondrial-based Therapeutics Market Size by Application (2025-2030)
        9.3.3 Asia Mitochondrial-based Therapeutics Market Share by Application (2019-2030)
    9.4 Asia Mitochondrial-based Therapeutics Market Size by Region
        9.4.1 Asia Mitochondrial-based Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Mitochondrial-based Therapeutics Market Size by Region (2019-2024)
        9.4.3 Asia Mitochondrial-based Therapeutics Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

 10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

 11 Key Players Profiles
    11.1 Reneo Pharmaceutical
        11.1.1 Reneo Pharmaceutical Company Details
        11.1.2 Reneo Pharmaceutical Business Overview
        11.1.3 Reneo Pharmaceutical Mitochondrial-based Therapeutics Introduction
        11.1.4 Reneo Pharmaceutical Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.1.5 Reneo Pharmaceutical Recent Developments
    11.2 Pfizer Inc.
        11.2.1 Pfizer Inc. Company Details
        11.2.2 Pfizer Inc. Business Overview
        11.2.3 Pfizer Inc. Mitochondrial-based Therapeutics Introduction
        11.2.4 Pfizer Inc. Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.2.5 Pfizer Inc. Recent Developments
    11.3 Norvartis AG
        11.3.1 Norvartis AG Company Details
        11.3.2 Norvartis AG Business Overview
        11.3.3 Norvartis AG Mitochondrial-based Therapeutics Introduction
        11.3.4 Norvartis AG Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.3.5 Norvartis AG Recent Developments
    11.4 Takeda Pharmaceuticals
        11.4.1 Takeda Pharmaceuticals Company Details
        11.4.2 Takeda Pharmaceuticals Business Overview
        11.4.3 Takeda Pharmaceuticals Mitochondrial-based Therapeutics Introduction
        11.4.4 Takeda Pharmaceuticals Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.4.5 Takeda Pharmaceuticals Recent Developments
    11.5 Amgen Inc.
        11.5.1 Amgen Inc. Company Details
        11.5.2 Amgen Inc. Business Overview
        11.5.3 Amgen Inc. Mitochondrial-based Therapeutics Introduction
        11.5.4 Amgen Inc. Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.5.5 Amgen Inc. Recent Developments
    11.6 NeuroVive Pharmaceutical AB
        11.6.1 NeuroVive Pharmaceutical AB Company Details
        11.6.2 NeuroVive Pharmaceutical AB Business Overview
        11.6.3 NeuroVive Pharmaceutical AB Mitochondrial-based Therapeutics Introduction
        11.6.4 NeuroVive Pharmaceutical AB Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.6.5 NeuroVive Pharmaceutical AB Recent Developments
    11.7 Entogene AG
        11.7.1 Entogene AG Company Details
        11.7.2 Entogene AG Business Overview
        11.7.3 Entogene AG Mitochondrial-based Therapeutics Introduction
        11.7.4 Entogene AG Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.7.5 Entogene AG Recent Developments
    11.8 Stealth Biotherapeutics
        11.8.1 Stealth Biotherapeutics Company Details
        11.8.2 Stealth Biotherapeutics Business Overview
        11.8.3 Stealth Biotherapeutics Mitochondrial-based Therapeutics Introduction
        11.8.4 Stealth Biotherapeutics Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.8.5 Stealth Biotherapeutics Recent Developments
    11.9 Ixchel Pharma
        11.9.1 Ixchel Pharma Company Details
        11.9.2 Ixchel Pharma Business Overview
        11.9.3 Ixchel Pharma Mitochondrial-based Therapeutics Introduction
        11.9.4 Ixchel Pharma Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.9.5 Ixchel Pharma Recent Developments
    11.10 Reata Pharmaceuticals
        11.10.1 Reata Pharmaceuticals Company Details
        11.10.2 Reata Pharmaceuticals Business Overview
        11.10.3 Reata Pharmaceuticals Mitochondrial-based Therapeutics Introduction
        11.10.4 Reata Pharmaceuticals Revenue in Mitochondrial-based Therapeutics Business (2019-2024)
        11.10.5 Reata Pharmaceuticals Recent Developments

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Mitochondrial-based Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral
    Table 3. Key Players of Intravenous
    Table 4. Global Mitochondrial-based Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Mitochondrial-based Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Mitochondrial-based Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Mitochondrial-based Therapeutics Market Share by Region (2019-2024)
    Table 8. Global Mitochondrial-based Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Mitochondrial-based Therapeutics Market Share by Region (2025-2030)
    Table 10. Mitochondrial-based Therapeutics Market Trends
    Table 11. Mitochondrial-based Therapeutics Market Drivers
    Table 12. Mitochondrial-based Therapeutics Market Challenges
    Table 13. Mitochondrial-based Therapeutics Market Restraints
    Table 14. Global Mitochondrial-based Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Mitochondrial-based Therapeutics Revenue Share by Players (2019-2024)
    Table 16. Global Top Mitochondrial-based Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitochondrial-based Therapeutics as of 2023)
    Table 17. Global Mitochondrial-based Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Mitochondrial-based Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Mitochondrial-based Therapeutics, Headquarters and Area Served
    Table 20. Global Key Players of Mitochondrial-based Therapeutics, Product and Application
    Table 21. Global Key Players of Mitochondrial-based Therapeutics, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Mitochondrial-based Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Mitochondrial-based Therapeutics Revenue Market Share by Type (2019-2024)
    Table 25. Global Mitochondrial-based Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Mitochondrial-based Therapeutics Revenue Market Share by Type (2025-2030)
    Table 27. Global Mitochondrial-based Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Mitochondrial-based Therapeutics Revenue Share by Application (2019-2024)
    Table 29. Global Mitochondrial-based Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Mitochondrial-based Therapeutics Revenue Share by Application (2025-2030)
    Table 31. North America Mitochondrial-based Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Mitochondrial-based Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Mitochondrial-based Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Mitochondrial-based Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Mitochondrial-based Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Mitochondrial-based Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Mitochondrial-based Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Mitochondrial-based Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Mitochondrial-based Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Mitochondrial-based Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Mitochondrial-based Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Mitochondrial-based Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Mitochondrial-based Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Mitochondrial-based Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Mitochondrial-based Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Mitochondrial-based Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Mitochondrial-based Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Mitochondrial-based Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Mitochondrial-based Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Mitochondrial-based Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Mitochondrial-based Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Mitochondrial-based Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Mitochondrial-based Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Mitochondrial-based Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Mitochondrial-based Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Reneo Pharmaceutical Company Details
    Table 64. Reneo Pharmaceutical Business Overview
    Table 65. Reneo Pharmaceutical Mitochondrial-based Therapeutics Product
    Table 66. Reneo Pharmaceutical Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. Reneo Pharmaceutical Recent Developments
    Table 68. Pfizer Inc. Company Details
    Table 69. Pfizer Inc. Business Overview
    Table 70. Pfizer Inc. Mitochondrial-based Therapeutics Product
    Table 71. Pfizer Inc. Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. Pfizer Inc. Recent Developments
    Table 73. Norvartis AG Company Details
    Table 74. Norvartis AG Business Overview
    Table 75. Norvartis AG Mitochondrial-based Therapeutics Product
    Table 76. Norvartis AG Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 77. Norvartis AG Recent Developments
    Table 78. Takeda Pharmaceuticals Company Details
    Table 79. Takeda Pharmaceuticals Business Overview
    Table 80. Takeda Pharmaceuticals Mitochondrial-based Therapeutics Product
    Table 81. Takeda Pharmaceuticals Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 82. Takeda Pharmaceuticals Recent Developments
    Table 83. Amgen Inc. Company Details
    Table 84. Amgen Inc. Business Overview
    Table 85. Amgen Inc. Mitochondrial-based Therapeutics Product
    Table 86. Amgen Inc. Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 87. Amgen Inc. Recent Developments
    Table 88. NeuroVive Pharmaceutical AB Company Details
    Table 89. NeuroVive Pharmaceutical AB Business Overview
    Table 90. NeuroVive Pharmaceutical AB Mitochondrial-based Therapeutics Product
    Table 91. NeuroVive Pharmaceutical AB Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 92. NeuroVive Pharmaceutical AB Recent Developments
    Table 93. Entogene AG Company Details
    Table 94. Entogene AG Business Overview
    Table 95. Entogene AG Mitochondrial-based Therapeutics Product
    Table 96. Entogene AG Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 97. Entogene AG Recent Developments
    Table 98. Stealth Biotherapeutics Company Details
    Table 99. Stealth Biotherapeutics Business Overview
    Table 100. Stealth Biotherapeutics Mitochondrial-based Therapeutics Product
    Table 101. Stealth Biotherapeutics Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 102. Stealth Biotherapeutics Recent Developments
    Table 103. Ixchel Pharma Company Details
    Table 104. Ixchel Pharma Business Overview
    Table 105. Ixchel Pharma Mitochondrial-based Therapeutics Product
    Table 106. Ixchel Pharma Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 107. Ixchel Pharma Recent Developments
    Table 108. Reata Pharmaceuticals Company Details
    Table 109. Reata Pharmaceuticals Business Overview
    Table 110. Reata Pharmaceuticals Mitochondrial-based Therapeutics Product
    Table 111. Reata Pharmaceuticals Revenue in Mitochondrial-based Therapeutics Business (2019-2024) & (US$ Million)
    Table 112. Reata Pharmaceuticals Recent Developments
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Mitochondrial-based Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Mitochondrial-based Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Oral Features
    Figure 4. Intravenous Features
    Figure 5. Global Mitochondrial-based Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Mitochondrial-based Therapeutics Market Share by Application: 2023 VS 2030
    Figure 7. Mitochondrial Myopathy Case Studies
    Figure 8. Leber’s heredity Optic Neuropathy Case Studies
    Figure 9. Leigh Syndrome Case Studies
    Figure 10. Mitochondrial DNA Depletion Syndrome Case Studies
    Figure 11. Other Case Studies
    Figure 12. Mitochondrial-based Therapeutics Report Years Considered
    Figure 13. Global Mitochondrial-based Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Mitochondrial-based Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Mitochondrial-based Therapeutics Market Share by Region: 2023 VS 2030
    Figure 16. Global Mitochondrial-based Therapeutics Market Share by Players in 2023
    Figure 17. Global Top Mitochondrial-based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitochondrial-based Therapeutics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Mitochondrial-based Therapeutics Revenue in 2023
    Figure 19. North America Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    Figure 21. North America Mitochondrial-based Therapeutics Market Share by Application (2019-2030)
    Figure 22. North America Mitochondrial-based Therapeutics Market Share by Country (2019-2030)
    Figure 23. United States Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Mitochondrial-based Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    Figure 27. Europe Mitochondrial-based Therapeutics Market Share by Application (2019-2030)
    Figure 28. Europe Mitochondrial-based Therapeutics Market Share by Country (2019-2030)
    Figure 29. Germany Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Mitochondrial-based Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    Figure 37. China Mitochondrial-based Therapeutics Market Share by Application (2019-2030)
    Figure 38. Asia Mitochondrial-based Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    Figure 40. Asia Mitochondrial-based Therapeutics Market Share by Application (2019-2030)
    Figure 41. Asia Mitochondrial-based Therapeutics Market Share by Region (2019-2030)
    Figure 42. Japan Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Mitochondrial-based Therapeutics Market Share by Country (2019-2030)
    Figure 52. Brazil Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Mitochondrial-based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Reneo Pharmaceutical Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 59. Pfizer Inc. Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 60. Norvartis AG Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 61. Takeda Pharmaceuticals Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 62. Amgen Inc. Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 63. NeuroVive Pharmaceutical AB Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 64. Entogene AG Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 65. Stealth Biotherapeutics Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 66. Ixchel Pharma Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 67. Reata Pharmaceuticals Revenue Growth Rate in Mitochondrial-based Therapeutics Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed

Description

Mitochondria are therefore vital for normal cellular function, including intracellular metabolic activities and signal transduction of various cellular pathways. They are involved in cellular ion homeostasis, oxidative stress, and apoptotic and necrotic cell death.

Market Analysis and Insights: Global Mitochondrial-based Therapeutics Market

Market Segmentation